1 / 23

Asia-Pacific Polyunsaturated Fatty Acids Market

Asia-Pacific Polyunsaturated Fatty Acids Market is projected to reach $1.98 billion in 2026, following a CAGR of 10.25% during the forecast period 2021-2026. The APAC PUFAs market is at the growing stage.<br>Visit: https://bisresearch.com/industry-report/asia-pacific-polyunsaturated-fatty-acids-market.html

mohitbis
Download Presentation

Asia-Pacific Polyunsaturated Fatty Acids Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. res Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table of Content Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Attribution: https://pixabay.com/photos/tire-rim-car-mechanic-114259/ Focus on Product (Omega 3 & Omega 6 Product), Application, Country-Wise Analysis and Forecast: 2021-2026 June 2022 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Copyright © 2022 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content Executive Summary .......................................................................... 24 Scope of the Study ........................................................................... 32 1.Markets ..................................................................................... 34 1.1 Industry Outlook .............................................................................................. 35 1.1.1Market Definition ......................................................................................... 35 1.1.2Supply Chain Analysis ................................................................................ 36 1.1.3Ecosystem/Ongoing Programs .................................................................. 37 1.1.3.1 Governments Initiatives ..................................................................................... 38 1.1.3.2 Consortiums and Associations .......................................................................... 39 1.1.4Patent Analysis ............................................................................................ 40 1.1.4.1 Patent Analysis (by Status) ................................................................................ 42 1.1.4.2 Patent Analysis (by Inventor Type) .................................................................... 43 1.1.4.3 Patents Analysis (by Patent Office) ................................................................... 44 1.1.5Supply Demand Analysis ............................................................................ 45 1.1.6Government Body Regulations in Asia-Pacific Region ........................... 47 1.2 Business Dynamics ......................................................................................... 50 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 1.2.1Business Drivers ......................................................................................... 50 1.2.1.1 Growing Awareness Regarding Health Benefits of Omega-3 ............................ 50 1.2.1.2 Increasing Cases of Chronic Diseases .............................................................. 51 1.2.1.3 Support from Government Organization and Institutions ................................... 53 1.2.2Business Challenges .................................................................................. 54 1.2.2.1 Volatility in the Prices of PUFA Sources ............................................................ 54 1.2.2.2 Harmful Effects of High Ratio Consumption ...................................................... 55 1.2.3Business Strategies .................................................................................... 56 1.2.3.1 Product Development ........................................................................................ 57 1.2.3.2 Market Development .......................................................................................... 57 3 All rights reserved at BIS Research Inc.

  4. 1.2.4Corporate Strategies ................................................................................... 58 1.2.4.1 Mergers and Acquisitions .................................................................................. 58 1.2.4.2 Partnerships, Collaborations, and Joint Ventures .............................................. 59 1.2.4.3 Others ................................................................................................................ 60 1.2.5Business Opportunities .............................................................................. 60 1.2.5.1 Increasing Aged Population ............................................................................... 60 1.2.5.2 Search for Innovative Sources of PUFA ............................................................ 61 1.2.5.3 Growing Market for Supplements in Asia-Pacific Region .................................. 62 1.3 A Shift in the Trend from Animal-Based to Plant-Based PUFAs Products ........................................................................................................... 65 1.4 Impact of COVID-19 on the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ................................................................................................ 70 2.Application ................................................................................ 71 2.1 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (By Application) ...................................................................................................... 72 2.1.1Pharmaceutical ............................................................................................ 72 2.1.2Dietary Supplements ................................................................................... 75 2.1.3Food and Beverages ................................................................................... 78 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 2.1.4Animal Feed ................................................................................................. 80 2.1.5Others (Cosmetics, etc.) ............................................................................. 82 2.2 Demand Analysis of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Application) .................................................................... 85 3.Products .................................................................................... 86 3.1 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Product Type) ................................................................................................................. 87 3.1.1Omega-3 ....................................................................................................... 87 3.1.1.1 Docosahexaenoic Fatty Acid (DHA) .................................................................. 87 4 All rights reserved at BIS Research Inc.

  5. 3.1.1.2 Others (Eicosapentanoic Fatty Acid (EPA) and Alpha-Linolenic Fatty Acid (ALA)) ................................................................................................................ 89 3.1.2Omega-6 ....................................................................................................... 95 3.1.2.1 Arachidonic Fatty Acid (ARA) ............................................................................ 96 3.1.2.2 Others Linoleic Fatty Acid (LA) and Gamma-Linolenic Fatty Acid (GLA) .......... 97 3.2 Demand Analysis of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Product Type) ................................................................. 98 3.3 Food Source ..................................................................................................... 99 3.3.1Plant Sources .............................................................................................. 99 3.3.1.1 Microalgae ......................................................................................................... 99 3.3.1.2 Others (Vegetables, Seeds) ............................................................................ 100 3.3.2Animal Sources ......................................................................................... 103 3.3.2.1 Fish .................................................................................................................. 104 3.3.2.2 Shrimp ............................................................................................................. 105 3.3.2.3 Others .............................................................................................................. 106 3.4 Demand Analysis of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source) ................................................................ 110 3.5 Forms .............................................................................................................. 111 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 3.5.1Triglycerides .............................................................................................. 111 3.5.2Ethyl Esters ................................................................................................ 113 3.5.3Others (Re-Esterified Triglyceride (rTG)) ................................................ 115 3.6 Demand Analysis of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Forms) ........................................................................... 116 4.Countries ................................................................................. 117 4.1 China ............................................................................................................... 122 4.1.1Market ......................................................................................................... 125 4.1.1.1 Buyer Attributes ............................................................................................... 125 4.1.1.2 Key Companies Operating in China ................................................................ 125 5 All rights reserved at BIS Research Inc.

  6. 4.1.1.3 Business Challenges ....................................................................................... 125 4.1.1.4 Business Drivers .............................................................................................. 125 4.1.2Application ................................................................................................. 126 4.1.2.1 China Polyunsaturated Fatty Acids (PUFAs) Market (by Application) ............. 126 4.1.3Product ....................................................................................................... 126 4.1.3.1 China Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source) .......... 126 4.2 India ................................................................................................................ 127 4.2.1Market ......................................................................................................... 128 4.2.1.1 Buyer Attributes ............................................................................................... 128 4.2.1.2 Key Companies Operating in India .................................................................. 128 4.2.1.3 Business Challenges ....................................................................................... 128 4.2.1.4 Business Drivers .............................................................................................. 129 4.2.2Application ................................................................................................. 129 4.2.2.1 India Polyunsaturated Fatty Acids (PUFAs) Market (by Application) ............... 129 4.2.3Product ....................................................................................................... 129 4.2.3.1 India Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source) ............ 129 4.3 Japan .............................................................................................................. 130 4.3.1Market ......................................................................................................... 131 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 4.3.1.1 Buyer Attributes ............................................................................................... 131 4.3.1.2 Key Companies Operating in Japan ................................................................ 132 4.3.1.3 Business Challenges ....................................................................................... 132 4.3.1.4 Business Drivers .............................................................................................. 132 4.3.2Application ................................................................................................. 133 4.3.2.1 Japan Polyunsaturated Fatty Acids (PUFAs) Market (by Application) ............. 133 4.3.3Product ....................................................................................................... 133 4.3.3.1 Japan Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source) .......... 133 4.4 South Korea ................................................................................................... 134 4.4.1Market ......................................................................................................... 136 6 All rights reserved at BIS Research Inc.

  7. 4.4.1.1 Buyer Attributes ............................................................................................... 136 4.4.1.2 Key Companies Operating in South Korea ...................................................... 136 4.4.1.3 Business Challenges ....................................................................................... 136 4.4.1.4 Business Drivers .............................................................................................. 137 4.4.2Application ................................................................................................. 138 4.4.2.1 South Korea Polyunsaturated Fatty Acids (PUFAs) Market (by Application) ......................................................................................................................... 138 4.4.3Product ....................................................................................................... 138 4.4.3.1 South Korea Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source) ............................................................................................................ 138 4.5 Singapore ....................................................................................................... 139 4.5.1Market ......................................................................................................... 140 4.5.1.1 Buyer Attributes ............................................................................................... 140 4.5.1.2 Key Companies Operating in Singapore ......................................................... 140 4.5.1.3 Business Challenges ....................................................................................... 140 4.5.1.4 Business Drivers .............................................................................................. 140 4.5.2Application ................................................................................................. 141 4.5.2.1 Singapore Polyunsaturated Fatty Acids (PUFAs) Market (by Application) ...... 141 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 4.5.3Product ....................................................................................................... 141 4.5.3.1 Singapore Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source) ......................................................................................................................... 141 4.6 Malaysia .......................................................................................................... 142 4.6.1Market ......................................................................................................... 143 4.6.1.1 Buyer Attributes ............................................................................................... 143 4.6.1.2 Key Companies Operating in Malaysia ............................................................ 143 4.6.1.3 Business Challenges ....................................................................................... 143 4.6.1.4 Business Drivers .............................................................................................. 143 4.6.2Application ................................................................................................. 144 4.6.2.1 Malaysia Polyunsaturated Fatty Acids (PUFAs) Market (by Application) ........ 144 7 All rights reserved at BIS Research Inc.

  8. 4.6.3Product ....................................................................................................... 144 4.6.3.1 Malaysia Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source) ..... 144 4.7 Thailand .......................................................................................................... 145 4.7.1Market ......................................................................................................... 145 4.7.1.1 Buyer Attributes ............................................................................................... 145 4.7.1.2 Key Companies Operating in Thailand ............................................................ 146 4.7.1.3 Business Challenges ....................................................................................... 146 4.7.1.4 Business Drivers .............................................................................................. 146 4.7.2Application ................................................................................................. 147 4.7.2.1 Thailand Polyunsaturated Fatty Acids (PUFAs) Market (by Application) ......... 147 4.7.3Product ....................................................................................................... 147 4.7.3.1 Thailand Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source) ...... 147 4.8 Australia and New Zealand ........................................................................... 148 4.8.1Market ......................................................................................................... 149 4.8.1.1 Buyer Attributes ............................................................................................... 149 4.8.1.2 Key Companies Operating in Australia and New Zealand ............................... 150 4.8.1.3 Business Challenges ....................................................................................... 150 4.8.1.4 Business Drivers .............................................................................................. 150 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 4.8.2Application ................................................................................................. 151 4.8.2.1 Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Application) ................................................................................................ 151 4.8.3Product ....................................................................................................... 151 4.8.3.1 Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source) ............................................................................................. 151 4.9 Rest-of-Asia-Pacific ....................................................................................... 152 4.9.1Market ......................................................................................................... 153 4.9.1.1 Buyer Attributes ............................................................................................... 153 4.9.1.2 Key Companies Operating in Rest-of-Asia-Pacific .......................................... 153 4.9.1.3 Business Challenges ....................................................................................... 154 8 All rights reserved at BIS Research Inc.

  9. 4.9.1.4 Business Drivers .............................................................................................. 154 4.9.2Application ................................................................................................. 154 4.9.2.1 Rest-of-Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Application) ...................................................................................................... 154 4.9.3Product ....................................................................................................... 155 4.9.3.1 Rest-of-Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source) ................................................................................................... 155 5. Markets - Competitive Benchmarking & Company Profiles ...... 156 5.1 Competitive Benchmarking .......................................................................... 157 5.2 Market Share Analysis .................................................................................. 159 5.3 Manufacturing Facility and Presence in Asia-Pacific ................................. 161 5.4 Company Profiles .......................................................................................... 163 5.4.1Aker BioMarine ASA .................................................................................. 163 5.4.1.1 Company Overview ......................................................................................... 163 5.4.1.2 Role of Aker BioMarine ASA in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ............................................................................................... 163 5.4.1.3 Product Portfolio .............................................................................................. 164 5.4.1.4 Business Strategies ......................................................................................... 164 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 5.4.1.4.1Product Launch ...................................................................................................... 164 5.4.1.5 Corporate Strategies ........................................................................................ 165 5.4.1.5.1Mergers and Acquisitions ....................................................................................... 165 5.4.1.5.2Partnerships, Collaborations, Joint Ventures, and Alliances ................................. 165 5.4.1.6 Strength and Weakness of Aker BioMarine ASA ............................................. 165 5.4.2BASF SE ..................................................................................................... 166 5.4.2.1 Company Overview ......................................................................................... 166 5.4.2.2 Role of BASF SE in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market .............................................................................................................. 166 5.4.2.3 Product Portfolio .............................................................................................. 167 5.4.2.4 Corporate Strategies ........................................................................................ 167 9 All rights reserved at BIS Research Inc.

  10. 5.4.2.4.1Partnerships, Collaborations, Joint Ventures, and Alliances ................................. 167 5.4.2.5 Strength and Weakness of BASF SE .............................................................. 168 5.4.3CABIO Biotech (Wuhan) Co., Ltd. ............................................................ 169 5.4.3.1 Company Overview ......................................................................................... 169 5.4.3.2 Role of CABIO Biotech (Wuhan) Co., Ltd in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ................................................. 169 5.4.3.3 Product Portfolio .............................................................................................. 170 5.4.3.4 Business Strategies ......................................................................................... 170 5.4.3.4.1Expansion .............................................................................................................. 170 5.4.3.4.2Product Launch ...................................................................................................... 171 5.4.3.5 Strength and Weakness of CABIO Biotech (Wuhan) Co., Ltd ......................... 171 5.4.4Cargill, Incorporated. ................................................................................ 172 5.4.4.1 Company Overview ......................................................................................... 172 5.4.4.2 Role of Cargill, Incorporated. in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ..................................................................................... 172 5.4.4.3 Product Portfolio .............................................................................................. 173 5.4.4.4 Business Strategies ......................................................................................... 173 5.4.4.4.1Market Development .............................................................................................. 173 5.4.4.4.2Product Developments ........................................................................................... 173 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 5.4.4.5 Strength and Weakness of Cargill, Incorporated. ............................................ 173 5.4.5Cellana, Inc. ............................................................................................... 175 5.4.5.1 Company Overview ......................................................................................... 175 5.4.5.2 Role of Cellana, Inc. in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ............................................................................................... 175 5.4.5.3 Product Portfolio .............................................................................................. 175 5.4.5.4 Corporate Strategies ........................................................................................ 176 5.4.5.4.1Partnerships, Joint Ventures, Collaborations, and Alliances ................................. 176 5.4.5.5 Strength and Weakness of Cellana, Inc. ......................................................... 176 5.4.6Clover Corporation .................................................................................... 177 5.4.6.1 Company Overview ......................................................................................... 177 10 All rights reserved at BIS Research Inc.

  11. 5.4.6.2 Role of Clover Corporation in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ............................................................................................... 177 5.4.6.3 Product Portfolio .............................................................................................. 178 5.4.6.4 Business Strategies ......................................................................................... 178 5.4.6.4.1Product Launch ...................................................................................................... 178 5.4.6.5 Strength and Weakness of Clover Corporation ............................................... 178 5.4.7Croda International PLC ........................................................................... 179 5.4.7.1 Company Overview ......................................................................................... 179 5.4.7.2 Role of Croda International PLC in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ..................................................................................... 179 5.4.7.3 Product Portfolio .............................................................................................. 180 5.4.7.4 Strength and Weakness of Croda International PLC ....................................... 180 5.4.8DSM ............................................................................................................ 181 5.4.8.1 Company Overview ......................................................................................... 181 5.4.8.2 Role of DSM in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market .... 181 5.4.8.3 Product Portfolio .............................................................................................. 182 5.4.8.4 Business Strategies ......................................................................................... 182 5.4.8.4.1Product Launch ...................................................................................................... 182 5.4.8.5 Corporate Strategies ........................................................................................ 182 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 5.4.8.5.1Partnerships, Joint Ventures, Collaborations, and Alliances ................................. 182 5.4.8.5.2Mergers and Acquisitions ....................................................................................... 183 5.4.8.6 Strength and Weakness of DSM ..................................................................... 183 5.4.9Guangdong Runke Bioengineering Co. Ltd. ........................................... 184 5.4.9.1 Company Overview ......................................................................................... 184 5.4.9.2 Role of Guangdong Runke Bioengineering Co. Ltd. in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ................................................. 184 5.4.9.3 Product Portfolio .............................................................................................. 184 5.4.9.4 Strength and Weakness of Guangdong Runke Bioengineering Co. Ltd. ......... 185 5.4.10Huatai ......................................................................................................... 186 5.4.10.1 Company Overview ......................................................................................... 186 11 All rights reserved at BIS Research Inc.

  12. 5.4.10.2 Role of Huatai in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ......................................................................................................................... 186 5.4.10.3 Product Portfolio .............................................................................................. 187 5.4.10.4 Strength and Weakness of Huatai ................................................................... 187 5.4.11Jindawei Group (Xiamen Kingdomway Group Company) ..................... 188 5.4.11.1 Company Overview ......................................................................................... 188 5.4.11.2 Role of Jindawei Group in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ............................................................................................... 188 5.4.11.3 Product Portfolio .............................................................................................. 188 5.4.11.4 Strength and Weakness of Jindawei Group .................................................... 189 5.4.12KinOmega Biopharm Inc ........................................................................... 190 5.4.12.1 Company Overview ......................................................................................... 190 5.4.12.2 Role of KinOmega Biopharm Inc in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ..................................................................................... 190 5.4.12.3 Product Portfolio .............................................................................................. 191 5.4.12.4 Strength and Weakness of KinOmega Biopharm Inc ...................................... 191 5.4.13Novasep ..................................................................................................... 192 5.4.13.1 Company Overview ......................................................................................... 192 5.4.13.2 Role of Novasep in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Market .............................................................................................................. 192 5.4.13.3 Product Portfolio .............................................................................................. 193 5.4.13.4 Corporate Strategies ........................................................................................ 193 5.4.13.4.1Mergers and Acquisitions ....................................................................................... 193 5.4.13.5 Strength and Weakness of Novasep ............................................................... 193 5.4.14NovoSana B.V. ........................................................................................... 194 5.4.14.1 Company Overview ......................................................................................... 194 5.4.14.2 Role of NovoSana B.V. in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ............................................................................................... 194 5.4.14.3 Product Portfolio .............................................................................................. 195 5.4.14.4 Business Strategies ......................................................................................... 195 12 All rights reserved at BIS Research Inc.

  13. 5.4.14.4.1Market Developments ............................................................................................ 195 5.4.14.5 Corporate Strategies ........................................................................................ 195 5.4.14.5.1Partnerships, Joint Ventures, Collaborations, and Alliances ................................. 195 5.4.14.6 Strength and Weakness of NovoSana B.V. ..................................................... 196 5.4.15Omega Protein Corporation ..................................................................... 197 5.4.15.1 Company Overview ......................................................................................... 197 5.4.15.2 Role of Omega Protein Corporation in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ..................................................................................... 197 5.4.15.3 Product Portfolio .............................................................................................. 198 5.4.15.4 Business Strategies ......................................................................................... 198 5.4.15.4.1Market Developments ............................................................................................ 198 5.4.15.5 Strength and Weakness of Omega Protein Corporation ................................. 199 5.4.16Pelagia AS .................................................................................................. 200 5.4.16.1 Company Overview ......................................................................................... 200 5.4.16.2 Role of Pelagia AS in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market .............................................................................................................. 200 5.4.16.3 Product Portfolio .............................................................................................. 201 5.4.16.4 Strength and Weakness of Pelagia AS ............................................................ 201 5.4.17Pharma Marine AS ..................................................................................... 202 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 5.4.17.1 Company Overview ......................................................................................... 202 5.4.17.2 Role of Pharma Marine AS in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ............................................................................................... 202 5.4.17.3 Product Portfolio .............................................................................................. 203 5.4.17.4 Corporate Strategies ........................................................................................ 203 5.4.17.4.1Partnerships, Collaborations, Joint Ventures, and Alliances ................................. 203 5.4.17.5 Strength and Weakness of Pharma Marine AS ............................................... 203 5.4.18Polaris ........................................................................................................ 204 5.4.18.1 Company Overview ......................................................................................... 204 5.4.18.2 Role of Polaris in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market .............................................................................................................. 204 13 All rights reserved at BIS Research Inc.

  14. 5.4.18.3 Product Portfolio .............................................................................................. 204 5.4.18.4 Business Strategies ......................................................................................... 205 5.4.18.4.1Product Launch ...................................................................................................... 205 5.4.18.5 Strength and Weakness of Polaris .................................................................. 205 5.4.19Sinomega Biotech Engineering Co., Ltd ................................................. 206 5.4.19.1 Company Overview ......................................................................................... 206 5.4.19.2 Role of Sinomega Biotech Engineering Co., Ltd in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ................................................. 206 5.4.19.3 Product Portfolio .............................................................................................. 207 5.4.19.4 Business Strategies ......................................................................................... 207 5.4.19.4.1Market Developments ............................................................................................ 207 5.4.19.5 Strength and Weakness of Sinomega Biotech Engineering Co., Ltd .............. 207 5.4.20Solutex ....................................................................................................... 208 5.4.20.1 Company Overview ......................................................................................... 208 5.4.20.2 Role of Solutex in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market .............................................................................................................. 208 5.4.20.3 Product Portfolio .............................................................................................. 209 5.4.20.4 Business Strategies ......................................................................................... 209 5.4.20.4.1Product Launch ...................................................................................................... 209 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 5.4.20.5 Corporate Strategies ........................................................................................ 209 5.4.20.5.1Partnership, Collaborations, Joint Ventures, and Alliances ................................... 209 5.4.20.6 Strength and Weakness of Solutex ................................................................. 210 5.4.21Stepan Company ....................................................................................... 211 5.4.21.1 Company Overview ......................................................................................... 211 5.4.21.2 Role of Stepan Company in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market ............................................................................................... 211 5.4.21.3 Product Portfolio .............................................................................................. 212 5.4.21.4 Corporate Strategies ........................................................................................ 212 5.4.21.4.1Mergers and Acquisitions ....................................................................................... 212 5.4.21.5 Strength and Weakness of Stepan Company .................................................. 212 14 All rights reserved at BIS Research Inc.

  15. 5.4.22Veramaris ................................................................................................... 213 5.4.22.1 Company Overview ......................................................................................... 213 5.4.22.2 Role of Veramaris in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market .............................................................................................................. 213 5.4.22.3 Product Portfolio .............................................................................................. 213 5.4.22.4 Corporate Strategies ........................................................................................ 214 5.4.22.4.1Partnerships, Joint Ventures, Collaborations, and Alliances ................................. 214 5.4.22.5 Strength and Weakness of Veramaris ............................................................. 214 5.4.23VivoMega .................................................................................................... 215 5.4.23.1 Company Overview ......................................................................................... 215 5.4.23.2 Role of VivoMega in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market .............................................................................................................. 215 5.4.23.3 Product Portfolio .............................................................................................. 216 5.4.23.4 Corporate Strategies ........................................................................................ 216 5.4.23.4.1Partnerships, Collaborations, Joint Ventures, and Alliances ................................. 216 5.4.23.5 Strength and Weakness of VivoMega ............................................................. 216 5.5 Final Product Companies in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market .............................................................................................. 217 6.Research Methodology ............................................................ 218 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 15 All rights reserved at BIS Research Inc.

  16. List of Figures Figure 1:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market, $Billion, 2020-2026 Figure 2:Market Dynamics of the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Figure 3:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Product Type), $Million, 2020-2026 Figure 4:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 Figure 5:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Forms), $Million, 2020-2026 Figure 6:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Figure 7:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Country), $Million, 2020 Figure 8:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Coverage Figure 9:Classification of Fatty Acid Figure 10:Supply Chain Analysis of Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Figure 11:Polyunsaturated Fatty Acids Patent Trend, 2019-2021 Figure 12:Patent Analysis (by Status), 2019-2021 Figure 13:Patent Analysis (by Status), 2019-2021 Figure 14:Patent Analysis (by Inventor Type), 2019-2021 Figure 15:Patents Analysis (by Patent Office), 2019-2021 Figure 16:Distribution of Cancer Related Death, Global, 2020 Figure 17:Cardiovascular Diseases (CVDs) Deaths, Asia, 1990-2019 Figure 18:Average Annual Price of Fish Oil, Global, January 2015-June 2019 Figure 19:Share of Key Market Strategies and Developments, 2018-2021 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Figure 20:Product Development and Innovation (by Company), 2018-2021 Figure 21:Market Development (by Company), 2018-2021 Figure 22:Mergers and Acquisitions (by Company), 2018-2021 Figure 23:Partnerships, Collaborations, and Joint Ventures (by Company), 2018-2021 Figure 24:Regional Population by Age Groups, Global, 2021 Figure 25:Share of Population Older than 65 Years, ASEAN Region, 2040 Figure 26:Market Size of Dietary Supplements, Global, 2018-2028 Figure 27:Market Value of Dietary Supplements, China, 2013-2020 Figure 28:Breakdown of Global Cosmetics Market, 2020 Figure 29:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Growth Matrix (by Country), $Million, 2020- 2026 Figure 30:Animal Feed Production (Value and Growth Rate), China, 2015-2023 Figure 31:Animal Feed Production (Volume and Growth Rate), China, 2015-2023 16 All rights reserved at BIS Research Inc.

  17. Figure 32:Changes in Animal Feed Composition, in percentage (%), China, 2015-2023 Figure 33:Trends in Domestic Pharmaceutical Market, Size and Imports/Exports, Value, Japan, 2015-2019 Figure 34:Trends in Domestic Pharmaceutical Market Size and Imports/Exports, Value, South Korea, 2018- 2020 Figure 35:Top Health Functional Foods Import Products, Value, South Korea, 2015-2019 Figure 36:Age Structure Between 2010 to 2020, Percentage (%), South Korea, 2010-2020 Figure 37:Sales Of Vitamins and Dietary Supplements Australia, Value, South Korea, 2018-2021 Figure 38:Competitive Benchmarking Matrix Figure 39:Market Share Analysis of Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market, 2020 Figure 40:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market: Research Methodology Figure 41:Top-Down and Bottom-Up Approach Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 17 All rights reserved at BIS Research Inc.

  18. List of Tables Table 1: Key Consortiums and Associations in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 2: Supply Demand Analysis Table 3: Recommendations for EPA and DHA Intake in Asia-Pacific Region Table 4: Recommendations for ARA Intake in Asia-Pacific Region Table 5: Products Pertaining to Pharmaceutical Industry in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 6: Products Pertaining to Dietary Supplements in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 7: Products Pertaining to Food and Beverages Industry in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 8: Products Pertaining to Animal Feed in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 9: Products Pertaining to Other Applications in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 10:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Table 11:Consumption of Docosahexaenoic Acid (DHA) Table 12:Consumption of Eicosapentaenoic Fatty Acid (EPA) Table 13:Consumption of Alpha-Linolenic Fatty Acid (ALA) Table 14:Products Pertaining to Omega-3 in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 15:Strategies and Development Pertaining to Omega-3 in the Polyunsaturated Fatty Acids (PUFAs) Market Table 16:Products Pertaining to Omega-6 in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 17:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Omega-3), $Million, 2020-2026 Table 18:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Omega-6), $Million, 2020-2026 Table 19:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Product Type), $Million, 2020-2026 Table 20:Nutrition Information of Algae Oil Supplements Table 21:Alpha-Linolenic Acid and Linoleic Acid Content Table 22:Products Pertaining to Plant Source in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 23:Strategies and Development Pertaining to Plant Source in the Polyunsaturated Fatty Acids (PUFAs) Market Table 24:Products Pertaining to Animal Source in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 18 All rights reserved at BIS Research Inc.

  19. Table 25:Strategies and Development Pertaining to Animal Source in the Polyunsaturated Fatty Acids (PUFAs) Market Table 26:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Plant Source), $Million, 2020-2026 Table 27:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Animal Source), $Million, 2020- 2026 Table 28:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 Table 29:Products Pertaining to Triglycerides (TGs) in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 30:Products Pertaining to Ethyl Esters in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 31:Products Pertaining to Other Forms in the Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 32:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Form), $Million, 2020-2026 Table 33:Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Country), $Million, 2020-2026 Table 34:Asia-Pacific Omega-3 Market (by Country), $Million, 2020-2026 Table 35:Asia-Pacific Omega-6 Market (by Country), $Million, 2020-2026 Table 36:China Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Table 37:China Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 Table 38:India Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Table 39:India Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 Table 40:Japan Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Table 41:Japan Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 42:South Korea Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Table 43:South Korea Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 Table 44:Singapore Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Table 45:Singapore Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 Table 46:Malaysia Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Table 47:Malaysia Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 Table 48:Thailand Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Table 49:Thailand Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 Table 50:Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Table 51:Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 19 All rights reserved at BIS Research Inc.

  20. Table 52:Australia and New Zealand Polyunsaturated Fatty Acids (PUFAs) Market (by Application), $Million, 2020-2026 Table 53:Rest-of-Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market (by Food Source), $Million, 2020-2026 Table 54:Manufacturing Facility in Asia-Pacific Table 55:Aker BioMarine ASA: Product Portfolio Table 56:Aker BioMarine ASA: Product Launch Table 57:Aker BioMarine ASA: Mergers and Acquisitions Table 58:Aker BioMarine ASA: Partnerships, Collaborations, Joint Ventures, and Alliances Table 59:BASF SE: Product Portfolio Table 60:BASF SE: Partnerships, Collaborations, Joint Ventures, and Alliances Table 61:CABIO Biotech (Wuhan) Co., Ltd: Product Portfolio Table 62:CABIO Biotech (Wuhan) Co., Ltd: Expansion Table 63:CABIO Biotech (Wuhan) Co., Ltd: Product Launch Table 64:Cargill, Incorporated.: Product Portfolio Table 65:Cargill, Incorporated.: Market Developments Table 66:Cargill, Incorporated.: Product Developments Table 67:Cellana, Inc.: Product Portfolio Table 68:Cellana, Inc.: Partnerships, Joint Ventures, Collaborations, and Alliances Table 69:Clover Corporation: Product Portfolio Table 70:Clover Corporation: Product Launch Table 71:Croda International PLC: Product Portfolio Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Table 72:DSM: Product Portfolio Table 73:DSM: Product Launch Table 74:DSM: Partnerships, Joint Ventures, Collaborations and Alliances Table 75:DSM: Mergers and Acquisitions Table 76:Guangdong Runke Bioengineering Co. Ltd.: Product Portfolio Table 77:Huatai: Product Portfolio Table 78:Jindawei Group: Product Portfolio Table 79:KinOmega Biopharm Inc: Product Portfolio Table 80:Novasep: Product Portfolio Table 81:Novasep: Mergers and Acquisitions Table 82:NovoSana B.V.: Product Portfolio Table 83:NovoSana B.V.: Market Developments Table 84:NovoSana B.V.: Partnerships, Joint Ventures, Collaborations, and Alliances 20 All rights reserved at BIS Research Inc.

  21. Table 85:Omega Protein Corporation: Product Portfolio Table 86:Omega Protein Corporation: Market Developments Table 87:Pelagia AS: Product Portfolio Table 88:Pharma Marine AS: Product Portfolio Table 89:Pharma Marine AS: Partnerships, Collaborations, Joint Ventures, and Alliances Table 90:Polaris: Product Portfolio Table 91:Polaris: Product Launch Table 92:Sinomega Biotech Engineering Co., Ltd: Product Portfolio Table 93:Sinomega Biotech Engineering Co., Ltd: Market Developments Table 94:Solutex: Product Portfolio Table 95:Solutex: Product Launch Table 96:Solutex: Partnership, Collaboration, Joint Ventures, and Alliances Table 97:Stepan Company: Product Portfolio Table 98:Stepan Company: Mergers and Acquisitions Table 99:Veramaris: Product Portfolio Table 100:Veramaris: Partnership, Joint Venture, Collaborations, and Alliances Table 101:VivoMega: Product Portfolio Table 102:VivoMega: Partnerships, Collaborations, Joint Ventures and Alliances Table 103:Final Product Companies in Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 21 All rights reserved at BIS Research Inc.

  22. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market 22 All rights reserved at BIS Research Inc.

  23. Asia-Pacific Polyunsaturated Fatty Acids (PUFAs) Market BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 www.bisresearch.com 23 All rights reserved at BIS Research Inc.

More Related